SCHEMBL4690080

SCHEMBL4690080

COc1ccc(CNc2ncnc3cc(OC)c(OC4CCOC4)cc23)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.70
KMT2A Q03164 2/20 0.70
HTT P42858 5/20 0.59
KDM4E B2RXH2 3/20 0.59
ALDH1A1 P00352 1/20 0.59
ERBB2 P04626 1/20 0.59
EPHA2 P29317 1/20 0.59
KDR P35968 1/20 0.59
EPHB4 P54760 1/20 0.59
MAPK1 P28482 3/20 0.58
EGFR P00533 8/20 0.57
LMNA P02545 2/20 0.57
HPGD P15428 1/20 0.57
LCK P06239 1/20 0.56
PDE5A O76074 2/20 0.55
POLB P06746 2/20 0.50
RAF1 P04049 1/20 0.50
MAPT P10636 1/20 0.50
BLM P54132 1/20 0.50
NR2F2 P24468 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4690253 0.94 MEN1 (0.73) MEN1KMT2AHTTKDM4EALDH1A1
SCHEMBL4688706 0.86 MEN1 (0.69) MEN1KMT2AHTTKDM4EALDH1A1
SCHEMBL6181626 0.84 MEN1 (1.00) MEN1KMT2AHTTKDM4EALDH1A1
SCHEMBL4686940 0.79 MEN1 (0.69) MEN1KMT2AHTTKDM4EALDH1A1
SCHEMBL4689349 0.78 MEN1 (0.68) MEN1KMT2AHTTKDM4EALDH1A1
SCHEMBL14001708 0.76 SOS1 (0.73) ERBB2EPHA2KDREPHB4EGFR
SCHEMBL23142515 0.76 EPHA2 (0.62) ERBB2EPHA2KDREPHB4EGFR
SCHEMBL4689340 0.76 EPHA2 (0.57) ERBB2EPHA2KDREPHB4EGFR
SCHEMBL23142519 0.76 EPHA2 (0.62) ERBB2EPHA2KDREPHB4EGFR
SCHEMBL30250789 0.76 EPHA2 (0.62) ERBB2EPHA2KDREPHB4EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1296973-B1 GUANIDINE DERIVATIVES OF QUINAZOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES ASTRAZENECA AB (SE) 2008-11-05 EP disclosed
US-7001904-B1 Guanidine derivatives quinazoline and quinoline for use in the treatment of autoimmune diseases ASTRAZENECA AB (SE) 2006-02-21 US disclosed